![Treatment of Myelodysplastic Syndromes with Orally Administered l-β-Z)-Arabinofuranosylcytosine-5’-Stearylphosphate]()
Treatment of Myelodysplastic Syndromes with Orally Administered l-β-Z)-Arabinofuranosylcytosine-5’-StearylphosphateOhno, Ryuzo; Tatsumi, Noriyuki; Hirano, Masami; Imai, Kuniyuki; Mizoguchi, Hideaki; Nakamura, Tohru; Kosaka, Masaaki; Takatsuki, Kiyoshi; Yamaya, Toshihiko; Toyama, Keisuke; Yoshida, Takashi; Masaoka, Tohru; Hashimoto, Shuji; Ohshima, Toshiteru; Kimura, Ikuro; Yamada, Kazumasa; Kimura, Kiyoji · Oncology · 1991